The purpose of this study is to determine the effectiveness and safety of mitomycin C in the treatment of primary sclerosing cholangitis (PSC).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
130
Johns Hopkins Hospital
Baltimore, Maryland, United States
RECRUITINGTherapeutic Effect on Disease Prognosis as Determined by the Mayo Natural History Model for Primary Sclerosing Cholangitis
Time frame: Two years
Number of Patients with Adverse Events
Time frame: Two years
Frequency of Endoscopic Interventions Needed to Manage Disease-related Complications
Time frame: Two years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.